June 4, 2021
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology
Partnership aims to leverage spatial biology data, generated on Akoya’s Phenoptics™ platform, to inform and guide drug development programs MARLBOROUGH, Mass., June 04, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today announced a collaboration...

Continue Reading
June 2, 2021
Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Applications
Company launches Advanced Biopharma Solutions (ABS), as the first pillar of the program, to enable spatial biomarker-guided drug development and clinical trials MARLBOROUGH, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company ® , today...

Continue Reading
May 18, 2021
Akoya Reports First Quarter 2021 Financial Results and Issues Full Year 2021 Guidance
MARLBOROUGH, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter ending March 31, 2021. First Quarter Financial Highlights: Total revenue for the first quarter of 2021 was...

Continue Reading
May 17, 2021
Akoya and ZEISS to Co-Market Innovative CODEX® Spatial Biology Workflow
The partnership brings together one of the world’s premier microscopy vendors and Akoya’s high-parameter CODEX® System for advancing the emerging field of spatial phenotyping and discovery MARLBOROUGH, Mass., May 17, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial...

Continue Reading
May 12, 2021
Akoya to Report First Quarter 2021 Financial Results on May 18, 2021
MARLBOROUGH, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will release financial results for the first quarter of 2021 after the market close on Tuesday, May 18, 2021....

Continue Reading
May 11, 2021
Akoya Biosciences Begins Accepting Applications for First-of-its-Kind Imaging Innovators (I²) Network
Seeking researchers interested in pushing the boundaries of spatial biology and discovery through the CODEX® system’s open, accessible interface MARLBOROUGH, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced that its...

Continue Reading
April 20, 2021
Akoya Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
MARLBOROUGH, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced the closing of its initial public offering of 7,567,000 shares of its common stock, including the exercise in full by the underwriters of their...

Continue Reading
April 15, 2021
Akoya Biosciences Announces Pricing of Initial Public Offering
MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6...

Continue Reading
April 5, 2021
Akoya Appoints Industry Leader Frederic Pla as Chief Operating Officer to Spearhead Growth Initiatives
Accomplished executive brings deep scientific and operational expertise Marlborough, MA. — April 5, 2021 — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced the appointment of Frederic Pla, PhD, as Chief Operating Officer. Dr. Pla will play a key role in preparing the company...

Continue Reading
March 23, 2021
Akoya to Help Support the Human Cell Atlas (HCA) Initiative with Single-Cell, Spatial Imaging Capabilities
CODEX’s spatial phenotyping capabilities will contribute to HCA investigators’ ability to build comprehensive tissue maps. MARLBOROUGH, Mass. — March 23, 2021 — Akoya Biosciences, Inc., The Spatial Biology Company®, today announced its support for the Human Cell Atlas (HCA) initiative, offering the...

Continue Reading
Displaying 11 - 20 of 22

Search Investor Relations